Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

KWALITY PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.147.596.313.673.07

What is the latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS is 12.14 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.14
Mar20247.59
Mar20236.31
Mar20223.67
Mar20213.07

How is EV/Core EBITDA of KWALITY PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.14
59.95
Mar2024 7.59
20.29
Mar2023 6.31
71.93
Mar2022 3.67
19.54
Mar2021 3.07 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹1,561.1 Cr 14.7% 3.1% 64.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹98,210.2 Cr -1.7% -8.4% -16.7% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

14.7%

3.1%

64.9%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses